Thursday, October 22, 2026 Published by AdvancedCare USA Inc.

TheraNews
Subscribe

Archive summary

Biogen to Present New Late-Breaking Litifilimab Phase 2 AMETHYST Data in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting

Summary of reporting by biospace 1 min read Markdown

Biogen to Present New Late-Breaking Litifilimab Phase 2 AMETHYST Data in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting

Originally reported by biospace. Read more

Source: https://www.biospace.com/press-releases/biogen-to-present-new-late-breaking-litifilimab-phase-2-amethyst-data-in-cutaneous-lupus-erythematosus-at-2026-american-academy-of-dermatology-annual-meeting

Newsletter

The weekly digest

Weekly digest of US behavioral health policy and regulation, source-linked and practitioner-edited. Free; unsubscribe in one click.